BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37913742)

  • 1. Group interpersonal psychotherapy (IPT-G) for borderline personality disorder: A randomized controlled study.
    Bozzatello P; Blua C; Marin G; Rocca P; Bellino S
    J Psychiatr Res; 2023 Dec; 168():157-164. PubMed ID: 37913742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpersonal Psychotherapy as a Single Treatment for Borderline Personality Disorder: A Pilot Randomized-Controlled Study.
    Bozzatello P; Bellino S
    Front Psychiatry; 2020; 11():578910. PubMed ID: 33061926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Interpersonal Psychotherapy Changes the Brain: A Study of fMRI in Borderline Personality Disorder.
    Bozzatello P; Morese R; Valentini MC; Rocca P; Bellino S
    J Clin Psychiatry; 2021 Nov; 83(1):. PubMed ID: 34792871
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined therapy with interpersonal psychotherapy adapted for borderline personality disorder: A two-years follow-up.
    Bozzatello P; Bellino S
    Psychiatry Res; 2016 Jun; 240():151-156. PubMed ID: 27107668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy.
    Bellino S; Rinaldi C; Bogetto F
    Can J Psychiatry; 2010 Feb; 55(2):74-81. PubMed ID: 20181302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of borderline personality disorder with interpersonal psychotherapy and pharmacotherapy: predictors of response.
    Bellino S; Bozzatello P; Bogetto F
    Psychiatry Res; 2015 Mar; 226(1):284-8. PubMed ID: 25677397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological therapies for people with borderline personality disorder.
    Stoffers JM; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD005652. PubMed ID: 22895952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2007 Nov; 52(11):718-25. PubMed ID: 18399039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2006 Jun; 51(7):453-60. PubMed ID: 16838827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Interpersonal Problems in Borderline Personality Disorder Inpatients on Treatment Outcome and Psychopathology.
    Dammann G; Riemenschneider A; Walter M; Sollberger D; Küchenhoff J; Gündel H; Clarkin JF; Gremaud-Heitz DJ
    Psychopathology; 2016; 49(3):172-80. PubMed ID: 27351438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study.
    Amianto F; Ferrero A; Pierò A; Cairo E; Rocca G; Simonelli B; Fassina S; Abbate-Daga G; Fassino S
    BMC Psychiatry; 2011 Nov; 11():181. PubMed ID: 22103890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2005 Sep; 66(9):1111-5. PubMed ID: 16187767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological therapies for people with borderline personality disorder.
    Storebø OJ; Stoffers-Winterling JM; Völlm BA; Kongerslev MT; Mattivi JT; Jørgensen MS; Faltinsen E; Todorovac A; Sales CP; Callesen HE; Lieb K; Simonsen E
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012955. PubMed ID: 32368793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpersonal psychotherapy for borderline personality disorder.
    Bateman AW
    Clin Psychol Psychother; 2012; 19(2):124-33. PubMed ID: 22344752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interpersonal psychotherapy: a model of intervention for borderline personality disorder].
    Bellino S; Bozzatello P; De Grandi E; Bogetto F
    Riv Psichiatr; 2014; 49(4):158-63. PubMed ID: 25174691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 3 Forms of Early Intervention for Young People With Borderline Personality Disorder: The MOBY Randomized Clinical Trial.
    Chanen AM; Betts JK; Jackson H; Cotton SM; Gleeson J; Davey CG; Thompson K; Perera S; Rayner V; Andrewes H; McCutcheon L
    JAMA Psychiatry; 2022 Feb; 79(2):109-119. PubMed ID: 34910093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Omega-3 Fatty Acids and Valproic Acid in Treatment of Borderline Personality Disorder: A Follow-Up Study.
    Bozzatello P; Rocca P; Bellino S
    Clin Drug Investig; 2018 Apr; 38(4):367-372. PubMed ID: 29302857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.